Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07291024 · ClinicalTrials.gov registry record · NA
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
A NA study of Ischemic Stroke, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07291024: Recruiting NA study of Ischemic Stroke, sponsored by Mayo Clinic.
NCT07291024 is a NA study of Ischemic Stroke that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07291024, a NA study of Ischemic Stroke, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety, feasibility, and efficacy of vagus nerve stimulation (VNS) paired with mobility training to improve lower extremity function and gait in individuals with chronic ischemic stroke.
Primary Outcome
Total number of serious adverse events reported related to vagus nerve stimulation (VNS) or mobility training
Conditions Studied
Interventions
- OTHER Vagus nerve stimulation (VNS) paired with mobility training
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2029-01-01 |
| Phase | NA |
What NCT07291024 shows while recruiting
NCT07291024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Vagus nerve stimulation (VNS) paired with mobility training is the first listed.
NCT07291024 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07291024 about?
NCT07291024 is a clinical study titled "A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke". The purpose of this study is to evaluate the safety, feasibility, and efficacy of vagus nerve stimulation (VNS) paired with mobility training to improve lower extremity function and gait in individuals with chronic ischemic stroke.
What is the current status of trial NCT07291024?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-12-03. Estimated completion is 2029-01-01.
What conditions does trial NCT07291024 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT07291024?
The interventions under investigation include: Vagus nerve stimulation (VNS) paired with mobility training (OTHER).
Who is sponsoring clinical trial NCT07291024?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07291024 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07291024's enrollment target sits among peer trials
20 55th of 66 higher than 9 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
StrokeNet Thrombectomy Endovascular Platform
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
-
K01 Impacts of Lingual Endurance Exercise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI